Study Governance and Limitations
Cross-source consensus on Study Governance and Limitations from 1 sources and 6 claims.
1 sources · 6 claims
Risks & contraindications
Other
Other
Other
Highlighted claims
- Patient-level data will not be publicly released because of agreements and privacy requirements. — Development and cross-site validation of machine-learning models for diagnosis and prognosis of stable angina with and without obstructive coronary artery disease: a study protocol
- The analyses will use deidentified or anonymised data in secure institutional environments and report only aggregate results. — Development and cross-site validation of machine-learning models for diagnosis and prognosis of stable angina with and without obstructive coronary artery disease: a study protocol
- Ethics approval has been obtained from review boards at the University of Calgary, Ottawa Health Science Network, and University Health Network. — Development and cross-site validation of machine-learning models for diagnosis and prognosis of stable angina with and without obstructive coronary artery disease: a study protocol
- Use of retrospective routinely collected records may require extensive imputation and introduce site-specific measurement bias. — Development and cross-site validation of machine-learning models for diagnosis and prognosis of stable angina with and without obstructive coronary artery disease: a study protocol
- Transportability to other health systems is uncertain because participating centres may share referral pathways and care protocols. — Development and cross-site validation of machine-learning models for diagnosis and prognosis of stable angina with and without obstructive coronary artery disease: a study protocol
- Dataset shift and calibration drift after deployment may require monitoring and model updates. — Development and cross-site validation of machine-learning models for diagnosis and prognosis of stable angina with and without obstructive coronary artery disease: a study protocol